Previous Phase 1b clinical data suggest niclosamide delivers favorable efficacy compared to topical corticosteroid in the treatment of ulcerative proctitis and ulcerative proctosigmoiditis BOCA RATON, ...

Salix Pharmaceuticals Ltd. said its two pivotal studies of budesonide foam in active to moderate ulcerative proctitis (UP) or ulcerative proctosigmoiditis (UPS) hit the primary endpoints, with a ...

Innovation Pharmaceuticals, a clinical stage pharmaceutical company, announced that patient screening for its phase 1 trial to investigate the use in healthy volunteers of delayed release tablets for ...

Eugenia Uche-Anya, MD, MPH, gastroenterology fellow at Massachusetts General Hospital, discusses the results of the case and important points to keep in mind when treating patients with mild UC: ...

The US Food and Drug Administration (FDA) has accepted Salix Pharmaceuticals' New Drug Application (NDA) filing for budesonide 2 mg rectal foam for the induction of remission in patients with active ...

Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post. Indices Commodities Currencies Stocks ...